Literature DB >> 10772655

Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis.

S Issazadeh1, K Abdallah, T Chitnis, A Chandraker, A D Wells, L A Turka, M H Sayegh, S J Khoury.   

Abstract

The mechanisms of chronic disease and recovery from relapses in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, are unknown. Deletion of myelin-specific lymphocytes by apoptosis may play a role in termination of the inflammatory response. One pathway of apoptosis is the passive cell death or "cell death by neglect" pathway, which is under the control of the Bcl family of genes. To investigate the role of passive cell death pathway in EAE, we used mice with transgenic expression of the long form of the bcl-x gene (Bcl-x(L)) targeted to the T-cell lineage. We found that mice transgenic for Bcl-x(L) have an earlier onset and a more chronic form of EAE induced by myelin oligodendrocyte glycoprotein (MOG) peptide 35-55 compared with wild-type littermate mice. This was not due to an expanded autoreactive cell repertoire. Primed peripheral lymphocytes from Bcl-x(L) transgenic mice showed increased proliferation and cytokine production to MOG peptide in vitro compared with lymphocytes from wild-type animals. Immunohistologic studies demonstrated increased cellular infiltrates, immunoglobulin precipitation, and demyelination in the Bcl-x(L) transgenic central nervous system (CNS) compared with controls. There was also a decreased number of apoptotic cells in the CNS of Bcl-x(L) transgenic mice when compared with littermates at all time points tested. This is the first report of an autoimmune disease model in Bcl-x(L) transgenic mice. Our data indicate that the passive cell death pathway is important in the pathogenesis of chronic EAE. These findings have implications for understanding the pathogenesis of multiple sclerosis and other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772655      PMCID: PMC300830          DOI: 10.1172/JCI8607

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice.

Authors:  Y Chen; W W Hancock; R Marks; P Gonnella; H L Weiner
Journal:  J Neuroimmunol       Date:  1998-03-01       Impact factor: 3.478

2.  Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.

Authors:  S Issazadeh; V Navikas; M Schaub; M Sayegh; S Khoury
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

Review 3.  Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

Authors:  L Van Parijs; A K Abbas
Journal:  Science       Date:  1998-04-10       Impact factor: 47.728

4.  Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis.

Authors:  B Bonetti; J Pohl; Y L Gao; C S Raine
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

5.  Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis.

Authors:  G C Suvannavejh; M C Dal Canto; L A Matis; S D Miller
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

6.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

Authors:  G E Deibler; R E Martenson; M W Kies
Journal:  Prep Biochem       Date:  1972

7.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

Authors:  D Hockenbery; G Nuñez; C Milliman; R D Schreiber; S J Korsmeyer
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

8.  The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis.

Authors:  C A White; P A McCombe; M P Pender
Journal:  J Neuroimmunol       Date:  1998-02       Impact factor: 3.478

9.  Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein.

Authors:  A Slavin; C Ewing; J Liu; M Ichikawa; J Slavin; C C Bernard
Journal:  Autoimmunity       Date:  1998       Impact factor: 2.815

10.  Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model.

Authors:  S Issazadeh; M Zhang; M H Sayegh; S J Khoury
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more
  7 in total

1.  The role of apoptosis in immune hyporesponsiveness following AAV8 liver gene transfer.

Authors:  Susan M Faust; Peter Bell; Yanqing Zhu; Julio Sanmiguel; James M Wilson
Journal:  Mol Ther       Date:  2013-10-15       Impact factor: 11.454

2.  Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.

Authors:  Koji Kishimoto; Sigrid Sandner; Jaime Imitola; Masayuki Sho; Yongsheng Li; Peter B Langmuir; David M Rothstein; Terry B Strom; Laurence A Turka; Mohamed H Sayegh
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

3.  Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease.

Authors:  Maureen A McGargill; Carmen Choy; Ben G Wen; Stephen M Hedrick
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

4.  Chronic mild hypoxia accelerates recovery from preexisting EAE by enhancing vascular integrity and apoptosis of infiltrated monocytes.

Authors:  Sebok K Halder; Richard Milner
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-05       Impact factor: 11.205

5.  High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

6.  Autoimmune-induced preferential depletion of myelin-associated glycoprotein (MAG) is genetically regulated in relapsing EAE (B6 x SJL) F1 mice.

Authors:  Dusanka S Skundric; Rujuan Dai; Vaagn L Zakarian; Weili Zhou
Journal:  Mol Neurodegener       Date:  2008-06-09       Impact factor: 14.195

7.  Early treatment with anti-VLA-4 mAb can prevent the infiltration and/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE.

Authors:  John E Mindur; Naoko Ito; Suhayl Dhib-Jalbut; Kouichi Ito
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.